From the Vault: Hip fractures in the elderly, like Tun Mahathir, are serious

Of particular concern are hip fractures as they carry a high death rate, especially since the elderly often have multiple ...

Radiotracers could improve choice of bladder cancer therapies

A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...

IV iron found to be most cost-effective treatment for women with iron deficiency anemia and heavy menstrual bleeding

A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding ...

BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer

BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious ...

From Kardashian Injectable Lips to Mar-a-Lago Face

Tressie McMillan Cottom, Jessica Grose and Meher Ahmad on why plastic surgery and fillers no longer feel like a secret — or a ...
Medical News Today

Wegovy pill: How does it compare to injections and what are the side effects?

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.
News-Medical.Net on MSN

IV iron dextran more cost-effective than oral iron for women with heavy menstrual bleeding and IDA

A single dose of intravenous (IV) iron dextran is the cost-effective treatment for women with heavy menstrual bleeding and ...

Pfizer, Astellas report positive phase 3 trial results for PADCEV combination in bladder cancer treatment

Pfizer Inc. (NYSE:PFE) is one of the most buzzing stocks to invest in according to hedge funds. Earlier on December 17, ...